IPHA vs VRTX: Which Stock is Better?
Side-by-side comparison of Innate Pharma Sa and Vertex Pharmaceuticals Inc in 2026
IPHA
Innate Pharma Sa
$1.69
VRTX
Vertex Pharmaceuticals Inc
$441.70
Key Metrics Comparison
| Metric | IPHA | VRTX | Winner |
|---|---|---|---|
| Market Cap | $152.94M | $113.01B | VRTX |
| P/E Ratio | N/A | 28.98 | VRTX |
| EPS (TTM) | $N/A | $15.33 | VRTX |
| Revenue Growth | -0.5% | 0.1% | VRTX |
| Gross Margin | -384.4% | 53.7% | VRTX |
Analyze IPHA
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IPHA or VRTX a better investment?
Comparing IPHA and VRTX: Innate Pharma Sa has a market cap of $152.94M while Vertex Pharmaceuticals Inc has $113.01B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IPHA and VRTX?
IPHA (Innate Pharma Sa) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IPHA or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IPHA or VRTX?
VRTX has higher revenue growth at 0.1% vs -0.5% for IPHA.
Which company is more profitable: IPHA or VRTX?
Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to -384.4% for IPHA.
Which is the larger company: IPHA or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $113.01B compared to $152.94M for IPHA.
Should I buy IPHA or VRTX in 2026?
Both IPHA and VRTX have investment merit. IPHA trades at $1.69 while VRTX trades at $441.70. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IPHA and VRTX stock?
Key differences: Market Cap ($152.94M vs $113.01B), P/E Ratio (N/A vs 29.0x), Revenue Growth (-0.5% vs 0.1%), Gross Margin (-384.4% vs 53.7%).